Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. METHODS: We performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. RESULTS: Exome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617A→C in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. CONCLUSIONS: Genetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic activating mutations of protein kinase A catalytic subunit (PRKACA) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
From Adrenal incidentaloma (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these mutations, the most frequently found (PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, depending on the convention used for numbering) with Arg and has been found in up to 67% of Cushing’s syndrome patients (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The L205R mutation was discovered independently in our laboratory and in other laboratories as the dominant genetic alteration in cortisol-producing adrenocortical adenomas responsible for Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later on, our group and others discovered single mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing’s syndrome, some degree of cortisol excess is present, depending on the diagnostic criteria applied,(4) in up to 47% of patients with adrenal…”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationPersistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
Research works printed but not linked: 1
- Bertherat J, 2003, Cancer Res, 63, 5308
Cited by
Items 401–475 of 475
Génomique intégrée des tumeurs bénignes corticosurrénaliennes
Faillot, S. (2017) · theses.fr (ABES) · doi:10.70675/36869127z1fb2z41bbzb082z1048e489a8e6
Nosé, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52480-3.50086-x
Genetics of Familial Forms of Cortisol-Secreting Adrenal Tumors and Hyperplasias
Drougat, L., & Stratakis, C. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64349-0
Self-citationGenetics of Familial Forms of Cortisol-Secreting Adrenal Tumors and Hyperplasias
Drougat, L., & Stratakis, C. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00417-9
Self-citationChasseloup, F. (2022) · theses.fr (ABES) · doi:10.70675/ddec5b6dzf376z4aadz9970zf0bf052c6f02
Cushing Syndrome; Screening and Differential Diagnosis
Lacroix, A., & Nieman, L. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65857-9
Genetics of Adrenocortical Tumors (ACT) and Hypersecretory Syndromes
Libé, R., Assié, G., Groussin, L., Bertherat, J. Y., & BERTAGNA, X. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00015-4
Self-citationEl antimilitarismo en el movimiento antiguerra
Barranco, C. P. (2003) · Africa América Latina, cuadernos: Revista de análisis sur-norte para una cooperación solidaria
Cushing syndrome—Unilateral adrenal adenoma
Dalmazi, G. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00221-1
Catalano, R., Peverelli, E., Giardino, E., Treppiedi, D., Morelli, V., Chiodini, I., Marcon, L., Ronchi, C. L., Bertherat, J. Y., Beuschlein, F., et al. (2017) · Endocrine Abstracts · doi:10.1530/endoabs.49.ep20
Self-citationEndocrine hypertension: From genes to biomarkers
Boulkroun, S., Zennaro, M., & Fernandes-Rosa, F. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00217-x
Characteristics and etiological profile of bilateral adrenal nodules: A Post-hoc analysis
Li, J., Xiong, Y., Li, J., Ma, L., Song, Y., Luo, R. H., Luo, Z., Mao, Y. J., Shen, H., Hu, J., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04576-w
Molecular Pathogenesis of Primary Adrenal Cushing’s Syndrome
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_4
Cushing syndrome in pediatrics: From molecular pathogenesis to therapeutic management
Nicolaides, N. C., & Stratakis, C. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00021-1
Self-citationNewell-Price, J. D. C. (2022) · doi:10.1093/med/9780198870197.003.0101
Hétérogénéité moléculaire de l'hyperplasie macronodulaire des surrénales
Vaczlavik, A. (2021) · theses.fr (ABES) · doi:10.70675/aed59e47zd6acz49b6z9c5ezc547c25b45ac
White, P. C. (2022) · Springer eBooks · doi:10.1007/978-3-319-31420-4_25-2
White, P. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-31420-4_25-1
Effet de la modulation de l'équilibre calcique dans le cortex surrénalien
Fedlaoui, B. (2023) · theses.fr (ABES) · doi:10.70675/45da36b4z01fdz47d6za4b6z8663da88f35d
Local protein kinase A signaling pathologies in the endocrine system
Cleveland, K. H., & Scott, J. D. (2026) · Molecular Pharmacology · doi:10.1016/j.molpha.2026.100128
Genetic Disorders of Adrenocortical Function
Hannah‐Shmouni, F., & Stratakis, C. A. (2016) · Endocrinology · doi:10.1007/978-3-319-27318-1_29-1
Self-citationGenetic Disorders of Adrenocortical Function
Hannah‐Shmouni, F., & Stratakis, C. A. (2017) · Endocrinology · doi:10.1007/978-3-319-27318-1_29-2
Self-citationMolecular mechanisms of pituitary adenoma tumorigenesis and invasiveness
Hage, M. P. (2018) · theses.fr (ABES) · doi:10.70675/e786f91cz4e92z40a0z97eaz3959187a3007
Primary Bilateral Macronodular Adrenal Hyperplasia
Koukoula, C., Kyriakopoulos, G., Tsagarakis, S., & Vassiliadi, D. A. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.01.005
Bilateral macronodular and micronodular hyperplasia: Biochemical, radiological and genetic diagnosis
Navas-Moreno, V., Ganga, C. S. L., Tapia-Sanchiz, M. S., Castro, M. A., & Marazuela, M. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2026.02.002
de Krijger, R. R., Tischler, A. S., Asa, S. L., Lack, E. E., & Volante, M. (2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-05
Genetic background of adrenocortical adenomas associated with hypercortisolism
Dalmazi, G. D. (2019) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.25072
Molecular Pathology of Endocrine Gland Tumors
Paola, F. J. D., Calafato, G., Rhoden, K. J., & Tallini, G. (2026) · Surgical pathology clinics · doi:10.1016/j.path.2026.01.004
Genetic factors in Cushing disease pathogenesis
Liu, N., Parsa, A. A., & Melmed, S. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00032-0
Chasseloup, F., & Kamenický, P. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102516
Broekema, M. F., Violon, F., Vaduva, P., Vogel, M., de Leeuw, N., & Komdeur, F. L. (2026) · Familial Cancer · doi:10.1007/s10689-026-00594-9
Moen, L. V. (2017) · NVA (Nasjonalt vitenarkiv)
Proteomic profiling reveals novel insights into hypercortisolism adrenal adenomas
Shi, X., Yang, Y. S., He, C., Xiong, Y., Zhang, W., Du, M., Chen, Z., Yin, J., Liu, Y., Qi, S., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156691
Olivieri, C., Wang, Y., Walker, C., Subrahmanian, M. V., Ha, K. N., Bernlohr, D., Gao, J., Camilloni, C., Vendruscolo, M., Taylor, S. S., et al. (2024) · eLife · doi:10.7554/elife.91506.2
Kuhn, A. W., Lerário, A. M., Charchar, H. L. S., Mariani, B. M. P., Vaduva, P., Nishi, M. Y., Ledesma, F. L., Srougi, V., Chambo, J. L., Mendonca, B. B., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag137
Self-citationLin, J., Li, Y., Huang, Z., Zhu, Y., Li, L., Yang, H., Liang, X., Qin, Y., Zhou, J., Xian, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26308966
Bathon, K. (2019) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-16893
Mohan, D. R. (2021) · Deep Blue (University of Michigan) · doi:10.7302/7242
PPNAD, Carney complex, and other micronodular adrenal hyperplasia
Vaduva, P., Espiard, S., & Bertherat, J. Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00124-2
Self-citationCarney complex with PRKAR1A mutation: A case report
Satyaraddi, A., & Chapla, A. (2016) · Australasian Medical Journal · doi:10.4066/amj.2016.2707
Primary Bilateral Macronodular Adrenal Hyperplasia
Lacroix, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64318-0
Arai, M., Ono, M., Inoue, R., Tajima, K., Aomori, K., Tatenuma, T., Suzuki, S., Yamanaka, S., Fujii, S., Terauchi, Y., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1852080
Drossart, T. (2025) · theses.fr (ABES) · doi:10.70675/3d7ac8c8z01e3z43b5z8286ze5ede0f2dec4
Tumorigenèse, progression tumorale et zonation fonctionnelle du cortex surrénalien
Drelon, C. (2014) · theses.fr (ABES) · doi:10.70675/27e6cd2az0b87z434cz8bfbz5a95cd080d8b
Espiard, S. (2016) · theses.fr (ABES) · doi:10.70675/02635c7ez7e0dz4130zb798z03dccf8dff23
Rôles des altérations des gènes CTNNB1 et de ZNRF3 dans les carsinomes de la corticosurrénale
Omeiri, H. (2017) · theses.fr (ABES) · doi:10.70675/fbda3f39z617az45c5zbb48z9b3cb87b5103
Génomique intégrée des tumeurs bénignes corticosurrénaliennes
Faillot, S., Néou, M., Garinet, S., Jouinot, A., Ragazzon, B., Espiard, S., Drougat, L., René-Corail, F., Perlemoine, K., Libé, R., et al. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.07.123
Self-citationViolon, F. (2024) · theses.fr (ABES) · doi:10.70675/2a411ad5zc9eez45b2za42cz4d39fe20187a
Génétique de l'hyperplasie macronodulaire bilatérale des surrénales : ARMC5 et KDM1A
Bouys, L. (2022) · theses.fr (ABES) · doi:10.70675/86c6abadzd86az4979zaba1z1a788b2c5e42
Lecoq, A.-L. (2015) · theses.fr (ABES) · doi:10.70675/47975cecze049z42f7z8ef3z035ffe201d2c
Functional characterisation of driver events in ovarian clear cell carcinoma
Gounaris, I. (2014) · Apollo (University of Cambridge) · doi:10.17863/cam.15891
Identification of novel genes involved in the pathophysiology of adrenocortical tumorigenesis
Doroszko, M. (2017) · UTUPub (University of Turku)
Walker, C. (2021) · University of Minnesota Digital Conservancy (University of Minnesota)
Remde, H., Kranz, S., Morell, S. M., Altieri, B., Kroiss, M., Detomas, M., Fassnacht, M., & Deutschbein, T. (2023) · doi:10.3389/fendo.2023.1123132.s001
Self-citationPittaway, J. F. H. (2023) · Queen Mary Research Online (Queen Mary University of London)
Molekulare Mechanismen der autonomen Aldosteronproduktion
Lichtenauer, U. (2018) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.24243
Ludwig, P. (2021) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.27443
Kardiovaskuläres Risiko bei Cushing Syndrom und subklinischem Cushing Syndrom
Krammer, C. (2021) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.27565
Investigação molecular de PBMAH familiar sem causa genética esclarecida
OLIVEIRA, G. C. D. S. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Syndromic Familial Nonmedullary Thyroid Carcinoma
Chu, Y., & Nosé, V. (2021) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5241-1
Syndromic Familial Nonmedullary Thyroid Carcinoma
Chu, Y., & Nosé, V. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62345-6_5241
Perinatal findings in a patient with a novel large chromosome 19p deletion
Čuljat, M., Razak, J., Saadeh‐Haddad, R., Driggers, R. W., Kamholz, K. L., & Timofeev, J. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1615
Aggarwal, S. (2018) · ResearchWorks at the University of Washington (University of Washington)
Substrate Identification of an Oncogenic Kinase: Elucidating the Pathogenesis of a Rare Liver Cancer
Jarmel, M. (2019) · Digital Commons - RU (Rockefeller University) · doi:10.48496/ry3g-dj44
Ultrasonic Reporter of Kinase Activity
Yang, J. W., Jin, Z., Wang, T., & Shapiro, M. G. (2026) · ACS Nano · doi:10.1021/acsnano.6c14484
Metadata
- Authors
- Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., Schaak, K., Schmittfull, A., Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E., Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T., Lohse, M. J., Reincke, M., Bertherat, J., Strom, T. M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Centre National de la Recherche Scientifique (FR)
- National Institutes of Health (US)
- Helmholtz Munich (DE)
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-03-13
- Volume
- 370
- Issue
- 11
- Pages
- 1019-1028
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4727447
- OpenAlex
- W2040816499
- Cited by
- 443
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 28 · 2023: 26 · 2022: 39 · 2021: 40 · 2020: 28 · 2019: 25 · 2018: 34 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 38
- FWCI
- 58.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- George Washington University
- Johns Hopkins University
- Cedars-Sinai Medical Center
- Quest Diagnostics
- Otsuka America
- European Commission (259735)
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008920)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal hyperplasia, PRKACA, protein kinase A catalytic subunit, somatic mutations, adrenocortical tumors, hypercortisolism
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Cushing Syndrome, Humans, Hydrocortisone, Middle Aged, Mutation, Protein Conformation, Sequence Analysis, DNA, Cyclic AMP-Dependent Protein Kinases, Germ-Line Mutation, Catalytic Domain, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.